
MOTS-c
MOTS-c is a mitochondrial-derived peptide of 16 amino acids encoded within the 12S rRNA region of mitochondrial DNA, studied in metabolic and ageing research for its role in regulating AMPK signalling and glucose homeostasis.
A mitochondria-derived peptide studied for its role in metabolic regulation, insulin sensitivity, and cellular energy homeostasis — an emerging longevity-pathway molecule.
For Research Use Only — Not for Human Consumption.
Sold strictly for in vitro laboratory research purposes.
In stock now
MOTS-c is out of stock. These are in stock.
Different compounds, matched on shared research goal and comparable cost per mg. They are not substitutes for one another — read the research on each page before you order.
- NAD+Cellular Energy & Redox ResearchSame goal · €0.69 / mgfrom €69
- SelankNootropic & Anxiolytic ResearchSame goal · €7.00 / mgfrom €35
- SemaxNeuroprotective & Cognitive ResearchSame goal · €7.00 / mgfrom €35
Email me when this batch returns
- Storage
- Store 2–8 °C. Reconstitute before use.
Mitochondrial Metabolic Research.
MOTS-c (CAS 1627580-64-6) is a 16-amino-acid peptide encoded within mitochondrial 12S rRNA. Research has examined its role in AMPK activation, skeletal muscle glucose uptake, and age-related metabolic decline reversal in preclinical models. Formula C121H200N42O22S2, MW 2174.71 g/mol.
- — Lee et al. — MOTS-c, AMPK pathway activation, and insulin sensitivity
- — Reynolds et al. — mitochondria-derived peptides and age-related metabolic decline reversal
Research context only. Not medical advice. Not for human or veterinary use.
- 10 mg lyophilised powder per vial
- Reconstitute with bacteriostatic water before use
- Store lyophilised at 2–8 °C, protect from light
- Once reconstituted, refrigerate and use within 14 days
- One 10 mg lyophilised MOTS-c vial
- Tamper-evident cap with batch-coded label
- Storage and reconstitution card
What the research reports about this molecule.
Classic parameters from peer-reviewed literature. Not human dosing guidance — read alongside the PubMed references on /learn.
- Sequence
- 16-amino-acid mitochondrial-derived peptide
- Molecular weight
- 1700 Da
- Mechanism
- Regulates AMPK signalling and glucose homeostasis
- Research domain
- Metabolic, ageing
- Reconstitution
- Bacteriostatic water, USP
- Storage
- Sealed: 2–8 °C, away from light; reconstituted: 2–8 °C, use within 14 days
From arrival to storage.
Laboratory handling notes for this compound. Peptyds products are supplied for research use only, not for human or veterinary use, so we give no dosing or administration guidance.
- 1
Store the sealed vial at 2–8 °C, away from light
- 2
Reconstitute with 2 mL bacteriostatic water — swirl gently
- 3
Label the vial with its batch number and reconstitution date
- 4
Refrigerate reconstituted vial; use within 14 days
Handling guide
Read the reconstitution guide
Reconstitution and storage for laboratory handling, step by step.
Reconstitution calculator
Research use onlySyringe
Peptide in vial
Bacteriostatic water
Concentration5 mg/mL
Target dose
Pull syringe to
5
units · 0.05 mL
Concentration
5
mg/mL
Doses per vial
40
doses
U-50 2.5 · U-40 2 units
For laboratory research calculation only. Not medical or dosing advice, and not for human or veterinary use.
Others researching Healthy Aging also compare
Everything worth asking before you order.
Shipping, storage, quality, and when to speak to a clinician — without the runaround.
Where can I find product information?
Product pages contain product details and research information. Contact us if you have a question about an item.
How much scientific detail is on each product page?
Product pages contain product details and research information. Contact us if you have a question about an item.
When will my order ship and arrive?
Dispatch timing can vary. We send tracking after the parcel is dispatched.
Why do clinics use NAD+ injections instead of NAD+ capsules?
Oral NAD+ is poorly absorbed intact, so most oral supplements use precursors — NR (nicotinamide riboside) or NMN (nicotinamide mononucleotide) — which the body converts to NAD+. Subcutaneous and IV NAD+ bypass first-pass metabolism and produce measurable plasma elevations in published pharmacokinetic work.
Are peptides safe long-term?
Honestly: it depends on the molecule. EMA-approved peptide drugs (semaglutide, tirzepatide, tesamorelin, thymalfasin in some jurisdictions) have multi-year safety datasets. Unapproved research peptides — BPC-157, TB-500, Melanotan II, Epithalon — have limited or no long-term human data.
How do I reconstitute a lyophilised peptide vial?
Bring both the lyophilised vial and the bacteriostatic water to room temperature, equalise pressure with a sterile vented needle, then inject the solvent slowly down the side of the vial. Swirl gently — never shake — until clear, and refrigerate at 2–8 °C.
How much bacteriostatic water should I add to my peptide vial?
The calculation is peptide mass (mg) ÷ desired concentration (mg/mL) = volume of bacteriostatic water in mL. For example, a 5 mg vial at 1 mg/mL needs 5 mL; at 2 mg/mL, 2.5 mL. Every Peptyds product page carries a suggested reconstitution volume tuned to the vial size.
How long does a reconstituted peptide stay stable in the fridge?
Most lyophilised peptides reconstituted with bacteriostatic water remain stable for 28–30 days at 2–8 °C, protected from light. A handful of short, fragile sequences — Epithalon among them — drop to roughly 14 days. Never freeze a reconstituted vial.
What side effects are most commonly reported across peptide research?
Across published trials and case series, the most frequent reported events are injection-site reactions (redness, induration, transient discomfort), headache, mild nausea, and temporary fatigue. GLP-1 and dual-agonist class peptides add dose-dependent gastrointestinal effects.
Who should not use peptides?
Peptides are not appropriate for anyone who is pregnant, nursing, planning conception, under 18, managing active cancer, or on immunosuppressants — and competitive athletes governed by WADA must avoid every peptide on the prohibited list. Anyone with a personal or family history of melanoma should specifically avoid melanocortin-receptor agonists.

